Search Results - "SAIGI, E"

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study by Martin-Richard, M., Gallego, R., Pericay, C., Foncillas, J. Garcia, Queralt, B., Casado, E., Barriuso, J., Iranzo, V., Juez, I., Visa, L., Saigi, E., Barnadas, A., Garcia-Albeniz, X., Maurel, J.

“…Summary Background Cisplatin and fluoropyrimidine (CF) are standard first- line treatment in advanced gastric cancer, but no second-line treatment has yet been…”
Get full text

P-082Three years of metastatic gastric cancer follow up in our hospital by Ferrer, M, Pericay, C, Macias Declara, I, Saigi, E, Dotor, E, Pisa, A

Get full text

A RETROSPECTIVE REVIEW OF PATIENTS WITH SCCHN TREATED WITH INDUCTION CHEMOTHERAPY BETWEEN 1999–2008 by Bontill, T, Aguilà, A.F, Mur, E, Escamilla, Y, Fernandez, L, Bonet, M, Roseli, R, Sole, J.M, Saigi, E, Segui, M.A

Get full text

Infiltrating ductal carcinoma: infiltrates at the exit site of a central venous access port device by Moya Horno, I., Fernández Morales, L.A., Dalmau Portulas, E., Seguí Palmer, M.A., Font Renom, J., Aparicio Rodríguez, O., Falcó Fages, J., Querol Niñerola, R., Pampols Felip, M., Saigí Grau, E.

Get full text

Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer by CIRERA, L, BALIL, A, BOLEDA, M, BATISTE-ALENTORN, E, TUSQUETS, I, CARDONA, T, ARCUSA, A, JOLIS, L, SAIGI, E, GUASCH, I, BADIA, A

“…The efficacy of adjuvant chemotherapy in gastric cancer is controversial. We conducted a phase III, randomized, multicentric clinical trial with the goal of…”
Get full text

Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer by Pericay, C., Serra-Aracil, X., Ocaña-Rojas, J., Mora-López, L., Dotor, E., Casalots, A., Pisa, A., Saigí, E.

“…Purpose Preoperative chemoradiotherapy and local excision via transanal endoscopic surgery (TEM) in T2–3s,N0,M0 rectal cancer achieve promising results in…”
Get full text

Gastrointestinal stromal tumors by Darnell, A, Dalmau, E, Pericay, C, Musulén, E, Martín, J, Puig, J, Malet, A, Saigí, E, Rey, M

“…We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings. We investigated a series…”
Get more information

Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma by Nogué, Miquel, Seguí, Miquel A., Saigí, Eugeni, Batiste‐Alentorn, Eduard, Arcusa, Angels, Boleda, Montserrat, Antón, Isabel

“…BACKGROUND Protracted oral administration of tegafur (TG) and leucovorin (LV) attempts to simulate the continuous infusion of 5‐fluorouracil, with a higher…”
Get full text

Multi-gene panels: new clinical experience in hereditary breast and ovarian cancer by Ramon y Cajal, T., Lasa, A., Llort, G., Lopez, C., Yagüe, C., Cornet, M., Gisbert, A., Fisas, D., Calvo, N., Vethencourt, A., Barba, A., Quero, S., Martinez, E., Hernan, I., Ruiz, A., Arcusa, A., Saigi, E., Barnadas, A., Surralles, J.

Get full text

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia by Mel, J. R., Salar, A., Rodríguez, C. A., Alegre, A., González, A., Cassinello, J., Montesinos, J., Gasquet, J. A., Sánchez, J., Saigí, E.

“…ABSTRACT Objective: Anaemia is common in cancer patients treated with chemotherapy. Darbepoetin alfa (DA) is the only erythropoiesis-stimulating protein…”
Get full text

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment by Manchon-Walsh, P, Aliste, L, Espinàs, J.A, Prades, J, Guarga, A, Balart, J, Biondo, S, Castells, A, Sanjuan, X, Tabernero, J, Borras, J.M

“…Abstract Background Rectal cancer surgery in Catalonia has been involved in a process of centralisation. We assessed the impact of this health policy strategy…”
Get full text

Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function by Carles, J, Nogué, M, Domènech, M, Pérez, C, Saigí, E, Villadiego, K, Guasch, I, Ibeas, R

“…Bladder cancer is a frequently occurring tumour in Spain and usually affects elderly patients with renal impairment. The development of new combination…”
Get more information

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC) by Roszkowski, Kazimierz, Pluzanska, Anna, Krzakowski, Maciej, Smith, Alexander Peter, Saigi, Eugeni, Aasebo, Ulf, Parisi, Annamaria, Pham Tran, Ngoc, Olivares, Robert, Berille, Jocelyne

“…This was an open-label randomized Phase III study of 207 patients with either unresectable or metastatic non-small cell lung cancer (NSCLC) who were treated…”
Get full text

6532 Prospective study of docetaxel in combination with cisplatin and an oral fluoropyrimidine in patients with gastric and esohagogastric junction adenocarcinoma by Pisa, A, Pericay, C, Losa, F, Nogué, M, Alfaro, J, Dotor, E, Bonfill, T, Querol, R, MoyaHorno, I, Saigí, E

Get full text

6116 Epidermal growth factor receptor (EGFR) expression in stage II-III colon carcinoma (CC) – nine years of follow-up by Pericay, C, Querol, R, Moya-Horno, I, Pisa, A, Dotor, E, Casalots, A, Bombardó, J, Bonfill, T, Saigí, E

Get full text

PO-065: A 23-year retrospective review of patients with nasopharyngeal carcinoma by Bonfill Abella, T, Escamilla Carpintero, Y, Aguilà Artal, A, Mur Restoy, E, Diaz Arguello, J, Garcia Perez, E, Seguí Palmer, M.A, Saigí Grau, E

Get full text

Five-year results of combined chemotherapy and mediastinal radiation therapy in small cell lung cancer by Bonfill, X, Lafuerza, A, Saigi, E, Palombo, H, Carulla, J, Fuentes, R, Rubio, D, Sole, L

“…Eighty-five patients with small cell lung cancer (limited disease = LD in 39, extensive disease = ED in 46) received the combination of cyclophosphamide,…”
Get more information

Analysis of the pathological response to primary chemotherapy in patients with locally advanced breast cancer (LABC) grouped according to ER, PR and HER2 status by Fernandez-Morales, L. A., Dalmau, E., Martinez, S., Arcusa, A., Pericay, C., Lain, J. M., Font, J., Tortajada, L., Saigi, E., Segui-Palmer, M. A.

“…Abstract only 626 Background: The determination of ER and PR has a considerable importance when evaluating the prognosis and the response to treatment in…”
Get full text

A multicenter study of trastuzumab (H) and vinorelbine (N) as first and second line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC) by Franquesa, R. M., Centelles, M., Villadiego, K., Janáriz, J., Arcusa, A., Cirera, L., Segui, M., Saigi, E.

“…Abstract only…”
Get full text

P-082 Three years of metastatic gastric cancer follow up in our hospital by Ferrer, M., Pericay, C., Macías Declara, I., Saigí, E., Dotor, E., Pisa, A.

Get full text